Tickerplace logo

Tickerplace

Monte Rosa Therapeutics, Inc. logo

GLUEMonte Rosa Therapeutics, Inc.

GLUE Stock Price, Valuation & Chart | Monte Rosa Therapeutics, Inc.

Compare
$14.220-0.09 (-0.63%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyGLUE intrinsic valueGLUE calculated fair value vs price
OverviewFinancialsDividendsRatios

GLUE Historical price chart

GLUE Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.20B
PE Ratio-8.13
EPS-1.75
Trading Volume1.53M
Today's High/Low15.0/13.8
Dividend Yield0.00
52 Week High/Low25.77/4.78
Shares Outstanding84.48M
GLUE Financial Statement
GLUE Analyst ratings
GLUE Analysis & performance metrics

GLUE Company profile

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms…

GLUE Management team

Management
Markus Warmuth M.D.CEO
President, Chief Executive Officer & Director
Philip Nickson J.D., Ph.D.
Chief Business & Legal Officer
Jennifer ChampouxCOO
Chief Operating Officer
Andrew Funderburk
Senior Vice President and Head of IR & Strategic Finance
Magnus Walter DPHIL
Senior Vice President of Drug Discovery
Filip Janku M.D., Ph.D.
Chief Medical Officer
Edmund Dunn
Senior Vice President & Corporate Controller
Sharon Townson Ph.D.
Chief Scientific Officer
Total 8 executives

GLUE Frequently asked questions

What is Monte Rosa Therapeutics, Inc. (GLUE) Stock Price?

Current stock price of Monte Rosa Therapeutics, Inc. (GLUE) stock is $14.220. The stock price is -0.63% lower in the session. The intraday range can be seen from this page. Volume of Monte Rosa Therapeutics, Inc. (GLUE) stock is 1.53M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Monte Rosa Therapeutics, Inc. (GLUE) stock price going up or down today?

The stock price of Monte Rosa Therapeutics, Inc. (GLUE) can change with earnings, company news, and overall market sentiment. Monte Rosa Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Monte Rosa Therapeutics, Inc. stock expensive at its current price?

Whether Monte Rosa Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GLUE on this page is -8.13. EPS on this page is -1.75. Compare those figures with peers and growth expectations before deciding if the current Monte Rosa Therapeutics, Inc. price is justified.

How has the stock price of Monte Rosa Therapeutics, Inc. (GLUE) performed historically?

Historical performance for Monte Rosa Therapeutics, Inc. (GLUE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GLUE reacted to past earnings and market events.

Should I buy Monte Rosa Therapeutics, Inc. (GLUE) stock, at this price?

Buying Monte Rosa Therapeutics, Inc. (GLUE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.